[Form 4] Cosmos Health Inc. Insider Trading Activity

Rhea-AI Filing Summary

Cosmos Health Inc. (COSM) insider Grigorios Siokas increased his stake through a debt-for-equity exchange. On 11/20/2025, the CEO, director and 10% owner acquired 51,315 shares of common stock at $0.6236 per share. The shares were issued as "Exchange Shares" in satisfaction of $32,000 that the company owed to him under a debt exchange agreement, using the fair market value of the stock on that date.

After this transaction, Siokas beneficially owned 6,271,813 shares held directly. This was a non-cash transaction for the company, converting a payable to equity while increasing the CEO’s direct ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last) (First) (Middle)

5 AG. GEORGIOU STR

PILEA

(Street)

THESSALONIKI J3 TK57001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.001	11/20/2025	11/20/2025	P(1)		51,315	A	$0.6236	6,271,813	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares are Exchange Shares being acquired by Grigorios Siokas, the Company's CEO, at the Exchange Rate of $0.6236 per share, the fair market value of the Common Stock on November 20, 2025, as an exchange to a total amount of $32,000 the Company owed to Mr. Siokas, pursuant to a debt exchange agreement between him and the Company.

Remarks:

	/s/ Grigorios Siokas	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cosmos Health Inc. (COSM) report?

Cosmos Health Inc. reported that its CEO, director and 10% owner Grigorios Siokas acquired 51,315 shares of common stock on 11/20/2025 through a debt-for-equity exchange.

At what price were the new Cosmos Health (COSM) shares issued to the CEO?

The 51,315 Cosmos Health common shares were issued to Grigorios Siokas at $0.6236 per share, reflecting the fair market value on November 20, 2025.

What amount of debt did Cosmos Health Inc. (COSM) exchange for shares?

Cosmos Health Inc. exchanged a total debt of $32,000 owed to CEO Grigorios Siokas for common stock, issuing 51,315 shares as Exchange Shares.

How many Cosmos Health (COSM) shares does the CEO own after this transaction?

Following the reported transaction, Grigorios Siokas beneficially owned 6,271,813 shares of Cosmos Health common stock directly.

Was cash paid in the Cosmos Health (COSM) insider share acquisition?

No cash changed hands; the 51,315 shares were issued as Exchange Shares in satisfaction of $32,000 in debt that the company owed to Grigorios Siokas.

What is the nature of the agreement behind the Cosmos Health (COSM) insider share issuance?

The issuance is pursuant to a debt exchange agreement between Cosmos Health Inc. and CEO Grigorios Siokas, under which company debt of $32,000 was exchanged for common stock at $0.6236 per share.